HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Small Personal Care Firms Rely On Good Contracts, Packaging Innovation As Ingredient Regs Loom

Executive Summary

Small- and medium-sized personal care marketers facing looming state and international laws banning or regulating ingredients and packaging must rely on well-written manufacturing contracts, says Debbie Waite, co-CEO of Steinberg & Associates, a regulatory consulting firm.

You may also be interested in...

PCPC’s International Efforts Focused On EU Microplastics Reg, China's CSAR Rollout

Francine Lamoriello, executive vice president of global strategies at the Personal Care Products Council, provided an overview of the group’s international activities at its 2022 Leadership Summit in Washington.

PCPC Working To Ensure State EPR Programs Are ‘Least Onerous As Possible’

The Personal Care Products Council is engaging on state legislation for extended producer responsibility programs, which impose the cost of recycling plastic materials on manufacturers. Emerging bills to prohibit use of the ‘chasing arrows’ recycling symbol on consumer packaging also have the trade group’s attention.

ECHA Exploring Cosmetic Microplastic Restrictions Under New EU Plastics Strategy

As part of its newly released plastics strategy, the European Commission has asked ECHA to prepare a proposal for restricting use of intentionally added microplastic particles in products including cosmetics. Industry groups will be weighing in on the initiative, which comes as a response to environmental concerns and increasing regulatory action at the EU member state level.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts